Interview with Jonathan Lifshitz, PhD, director of the translational neurotrauma research program at the College of Medicine – Phoenix, about his latest research into traumatic brain injuries and how they can affect an unborn child's development.

Average daily cases of COVID-19 have risen faster in Arizona than the wide majority of states over the previous two weeks, ranking in the top seven states across the country, according to data compiled by the New York Times as of Nov. 5.

The gift establishes endowed positions and scholarships and expands the History of Pharmacy Museum. The College renaming recognizes R. Ken Coit's support.

Copper has long been known to be antibacterial, but research led by Michael D. L. Johnson, PhD, shows how a special compound can be bound to copper to kill even antibiotic-resistant pathogens.

In the past few weeks Arizona attorney general Mark Brnovich, who is also running for U.S. Senate, has begun casting doubt on vaccine effectiveness far more openly.

Joel A. Dvoskin, PhD, a clinical assistant professor of psychiatry at the College of Medicine – Tucson, says reducing gun ownership to levels seen in peer countries is "literally impossible."

Rick Schnellmann, PhD, dean of the College of Pharmacy, announced a $50 million gift the college has received from UArizona alumnus R. Ken Coit. The college has been officially renamed the R. Ken Coit College of Pharmacy.

A clinical trial led by researchers at the University of Arizona Cancer Center helped Barbara Ann Jones overcome an unrelenting head and neck cancer.

Now that 5 to 11-year-olds are cleared to get Pfizer’s COVID-19 vaccine, some parents are concerned about adverse events from the shot.

A story focusing on the misinformation surrounding the COVID-19 pandemic mentions an interview in The Atlantic with Deepta Bhattacharya, PhD, an immunobiologist at the College of Medicine – Tucson.